OPRX
OptimizeRx Corp
Next earnings Aug 5, 2026 · consensus $0.13 EPS, $20.6M rev
Last earnings +2.1% on 2026-05-12
$4.90▼ -61.96%
over 1Y
L $4.54EODHDH $21.68
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today—
1W-1.6%
1M+1.4%
3M-29.6%
YTD-60.5%
1Y-62.0%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 13 analysts
Buy
Revenue grew 18.8% YoY.
OptimizeRx Corp shows $109M in FY2025 revenue (+18.8% YoY), a 4.7% net margin, and 4.0% ROE.
Sources: SEC EDGAR (CIK 0001448431, latest 10-Q filed 2026-05-13) · as of 6/26/2026, 5:49:27 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.